Nestle has a newly-acquired company, and it is the protein shake maker, Orgain. The latter produces plant-based bars, shakes, and protein powders, and the Swiss multinational food and drink processing company headquartered in Vevey, Vaud, Switzerland, bought a majority stake for an undisclosed amount.
Andrew Abraham, Orgain's founder, and Butterfly Equity will remain shareholders of the company once the deal is completed. According to Food Dive, the agreement between Nestle and Orgain includes the option for the former to buy the rest of the shares in the company in 2024. Abraham will also retain his position as the chief executive officer of Orgain.
It was said that the stake acquisition will push and step up Nestlé's efforts to grow its health and wellness business unit. To attain its goal, the company will also be removing some of its divisions that are growing slowly compared to the others.
In fact, Nestlé already offloaded its confections and ice cream businesses and last year, it has also disposed of the majority of its North American bottled waters business for $4.3 billion as it was already struggling to stay afloat.
With its new deal with Orgain, Nestle will also be able to focus more on its other international premium brands that have big potential to grow further such as Perrier. Orgain will also give the firm fresh products to offer especially with the growing demand for plant-based items around the world. Furthermore, Orgain will give Nestle a deeper presence in trendy categories that are becoming really popular with consumers.
"Nutritional protein plays a key role in supporting our health and wellness, whether we enjoy an active lifestyle or are facing health challenges," Nestlé Health Science chief executive officer, Greg Behar, said in a press release. "Orgain's emphasis on clean, all natural, plant-based, organic ingredients has made it a leader in the U.S., and we look forward to combining our companies' expertise to bring Orgain to more people around the world."
Dr. Abraham, CEO and Founder of Orgain, also said, "We've worked hard to develop innovative products that make a real difference in consumers' lives, and now through Nestlé Health Science's capabilities, resources and dedication to nutrition, we will be able to reach more people around the world."
Meanwhile, the acquisition deal is still subject to customary regulatory approvals.


Asian Markets End Year on AI Optimism as Precious Metals and Currencies Shine
U.S. Stock Index Futures Steady as Markets Await Fed Policy Clues in Holiday-Thinned Trade
One Percent Rule Checklist For Safer Forex Trading Risk
Oil Prices Stabilize at Start of 2026 as OPEC+ Policy and Geopolitical Risks Shape Market Outlook
China’s AI Models Narrow the Gap With the West, Says Google DeepMind CEO
TikTok Expands AI Age-Detection Technology Across Europe Amid Rising Regulatory Pressure
Wall Street Ends Mixed as Tech and Financial Stocks Weigh on Markets Amid Thin Holiday Trading
South Korean Won Slides Despite Government Efforts to Stabilize Currency Markets
U.S. Lawmakers Raise Alarm Over Trump Approval of Nvidia AI Chip Sales to China
Jamie Dimon Signals Possible Five More Years as JPMorgan CEO Amid Ongoing Succession Speculation
U.S. Dollar Slides Toward Biggest Annual Loss Since 2017 as 2026 Risks Loom
South Korea Factory Activity Returns to Growth in December on Export Rebound
Trump Delays Tariff Increases on Furniture and Cabinets for One More Year
Citi Forecasts a Volatile but Ongoing Bull Market for S&P 500 in 2026
Federal Judge Clears Way for Jury Trial in Elon Musk’s Fraud Lawsuit Against OpenAI and Microsoft
Oil Prices Slip Slightly as Markets Weigh Geopolitical Risks and Supply Glut Concerns
U.S. Dollar Steadies Ahead of Fed Minutes as Markets Eye Policy Divisions 



